These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 12558075)
1. Novel approaches to cancer therapy using oncolytic viruses. Stanziale SF; Fong Y Curr Mol Med; 2003 Feb; 3(1):61-71. PubMed ID: 12558075 [TBL] [Abstract][Full Text] [Related]
2. [Oncolytic viruses for genetic therapy of gastrointestinal tumors]. Bitzer M; Lauer UM Z Gastroenterol; 2003 Jul; 41(7):667-74. PubMed ID: 12858239 [TBL] [Abstract][Full Text] [Related]
3. Oncolytic viruses and cancer therapy. Norman KL; Farassati F; Lee PW Cytokine Growth Factor Rev; 2001; 12(2-3):271-82. PubMed ID: 11325607 [No Abstract] [Full Text] [Related]
4. Clinical development directions in oncolytic viral therapy. Eager RM; Nemunaitis J Cancer Gene Ther; 2011 May; 18(5):305-17. PubMed ID: 21436867 [TBL] [Abstract][Full Text] [Related]
5. Oncolytic viruses as novel anticancer agents: turning one scourge against another. Smith ER; Chiocca EA Expert Opin Investig Drugs; 2000 Feb; 9(2):311-27. PubMed ID: 11060679 [TBL] [Abstract][Full Text] [Related]
7. Oncolytic viruses as therapeutic agents. Wildner O Ann Med; 2001 Jul; 33(5):291-304. PubMed ID: 11491186 [TBL] [Abstract][Full Text] [Related]
8. Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer. Huang F; Wang BR; Wu YQ; Wang FC; Zhang J; Wang YG World J Gastroenterol; 2016 Sep; 22(35):7999-8009. PubMed ID: 27672294 [TBL] [Abstract][Full Text] [Related]
9. PML has a predictive role in tumor cell permissiveness to interferon-sensitive oncolytic viruses. Sobol PT; Hummel JL; Rodrigues RM; Mossman KL Gene Ther; 2009 Sep; 16(9):1077-87. PubMed ID: 19474810 [TBL] [Abstract][Full Text] [Related]
10. Targeted oncolytic herpes simplex viruses for aggressive cancers. Wong J; Lee C; Zhang K; Rennie PS; Jia W Curr Pharm Biotechnol; 2012 Jul; 13(9):1786-94. PubMed ID: 21740360 [TBL] [Abstract][Full Text] [Related]
11. Replicative oncolytic adenoviruses in multimodal cancer regimens. Post DE; Khuri FR; Simons JW; Van Meir EG Hum Gene Ther; 2003 Jul; 14(10):933-46. PubMed ID: 12869212 [TBL] [Abstract][Full Text] [Related]
12. Replication-selective viruses for cancer therapy. Biederer C; Ries S; Brandts CH; McCormick F J Mol Med (Berl); 2002 Mar; 80(3):163-75. PubMed ID: 11894142 [TBL] [Abstract][Full Text] [Related]
13. Newcastle disease virus as an oncolytic agent. Ravindra PV; Tiwari AK; Sharma B; Chauhan RS Indian J Med Res; 2009 Nov; 130(5):507-13. PubMed ID: 20090097 [TBL] [Abstract][Full Text] [Related]
14. [Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives]. Sviatchenko VA; Tarasova MV; Netesov SV; Chumakov PM Mol Biol (Mosk); 2012; 46(4):556-69. PubMed ID: 23113343 [TBL] [Abstract][Full Text] [Related]
15. Vesicular stomatitis virus as an oncolytic vector. Barber GN Viral Immunol; 2004; 17(4):516-27. PubMed ID: 15671748 [TBL] [Abstract][Full Text] [Related]